Literature DB >> 23897608

Dissection of the role of pili and type 2 and 3 secretion systems in adherence and biofilm formation of an atypical enteropathogenic Escherichia coli strain.

Rodrigo T Hernandes1, Miguel A De la Cruz, Denise Yamamoto, Jorge A Girón, Tânia A T Gomes.   

Abstract

Atypical enteropathogenic Escherichia coli (aEPEC) strains are diarrheal pathogens that lack bundle-forming pilus production but possess the virulence-associated locus of enterocyte effacement. aEPEC strain 1551-2 produces localized adherence (LA) on HeLa cells; however, its isogenic intimin (eae) mutant produces a diffuse-adherence (DA) pattern. In this study, we aimed to identify the DA-associated adhesin of the 1551-2 eae mutant. Electron microscopy of 1551-2 identified rigid rod-like pili composed of an 18-kDa protein, which was identified as the major pilin subunit of type 1 pilus (T1P) by mass spectrometry analysis. Deletion of fimA in 1551-2 affected biofilm formation but had no effect on adherence properties. Analysis of secreted proteins in supernatants of this strain identified a 150-kDa protein corresponding to SslE, a type 2 secreted protein that was recently reported to be involved in biofilm formation of rabbit and human EPEC strains. However, neither adherence nor biofilm formation was affected in a 1551-2 sslE mutant. We then investigated the role of the EspA filament associated with the type 3 secretion system (T3SS) in DA by generating a double eae espA mutant. This strain was no longer adherent, strongly suggesting that the T3SS translocon is the DA adhesin. In agreement with these results, specific anti-EspA antibodies blocked adherence of the 1551-2 eae mutant. Our data support a role for intimin in LA, for the T3SS translocon in DA, and for T1P in biofilm formation, all of which may act in concert to facilitate host intestinal colonization by aEPEC strains.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23897608      PMCID: PMC3811761          DOI: 10.1128/IAI.00620-13

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  56 in total

1.  Antibody against the carboxyl terminus of intimin alpha reduces enteropathogenic Escherichia coli adherence to tissue culture cells and subsequent induction of actin polymerization.

Authors:  Humberto M Carvalho; Louise D Teel; John F Kokai-Kun; Alison D O'Brien
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

2.  An inducible bundle-forming pilus of enteropathogenic Escherichia coli.

Authors:  J A Girón; A S Ho; G K Schoolnik
Journal:  Science       Date:  1991-11-01       Impact factor: 47.728

3.  Initial binding of Shiga toxin-producing Escherichia coli to host cells and subsequent induction of actin rearrangements depend on filamentous EspA-containing surface appendages.

Authors:  F Ebel; T Podzadel; M Rohde; A U Kresse; S Krämer; C Deibel; C A Guzmán; T Chakraborty
Journal:  Mol Microbiol       Date:  1998-10       Impact factor: 3.501

Review 4.  Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements.

Authors:  Alexander R C Wong; Jaclyn S Pearson; Michael D Bright; Diana Munera; Keith S Robinson; Sau Fung Lee; Gad Frankel; Elizabeth L Hartland
Journal:  Mol Microbiol       Date:  2011-05-05       Impact factor: 3.501

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 6.  Diarrheagenic Escherichia coli.

Authors:  J P Nataro; J B Kaper
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

7.  Characterization of atypical enteropathogenic Escherichia coli strains that express typical localized adherence in HeLa cells in the absence of the bundle-forming pilus.

Authors:  Rodrigo Tavanelli Hernandes; Mônica Aparecida Midolli Vieira; Sylvia Mendes Carneiro; Fábia Andréia Salvador; Tânia Aparecida Tardelli Gomes
Journal:  J Clin Microbiol       Date:  2006-09-06       Impact factor: 5.948

8.  Coiled-coil domain of enteropathogenic Escherichia coli type III secreted protein EspD is involved in EspA filament-mediated cell attachment and hemolysis.

Authors:  S J Daniell; R M Delahay; R K Shaw; E L Hartland; M J Pallen; F Booy; F Ebel; S Knutton; G Frankel
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

9.  A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens.

Authors:  T K McDaniel; K G Jarvis; M S Donnenberg; J B Kaper
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

Review 10.  Pathogenic Escherichia coli.

Authors:  James B Kaper; James P Nataro; Harry L Mobley
Journal:  Nat Rev Microbiol       Date:  2004-02       Impact factor: 60.633

View more
  17 in total

Review 1.  Expanding Role of Type II Secretion in Bacterial Pathogenesis and Beyond.

Authors:  Nicholas P Cianciotto; Richard C White
Journal:  Infect Immun       Date:  2017-04-21       Impact factor: 3.441

Review 2.  Recent advances in adherence and invasion of pathogenic Escherichia coli.

Authors:  Anjana Kalita; Jia Hu; Alfredo G Torres
Journal:  Curr Opin Infect Dis       Date:  2014-10       Impact factor: 4.915

3.  Finding Regulators Associated with the Expression of the Long Polar Fimbriae in Enteropathogenic Escherichia coli.

Authors:  Jia Hu; Brittany N Ross; Roberto J Cieza; Alfredo G Torres
Journal:  J Bacteriol       Date:  2015-09-08       Impact factor: 3.490

Review 4.  Intra- and inter-species interactions within biofilms of important foodborne bacterial pathogens.

Authors:  Efstathios Giaouris; Even Heir; Mickaël Desvaux; Michel Hébraud; Trond Møretrø; Solveig Langsrud; Agapi Doulgeraki; George-John Nychas; Miroslava Kačániová; Katarzyna Czaczyk; Hülya Ölmez; Manuel Simões
Journal:  Front Microbiol       Date:  2015-08-20       Impact factor: 5.640

5.  Pathogenic E. coli exploits SslE mucinase activity to translocate through the mucosal barrier and get access to host cells.

Authors:  Maria Valeri; Silvia Rossi Paccani; Magdalena Kasendra; Barbara Nesta; Laura Serino; Mariagrazia Pizza; Marco Soriani
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

6.  Influence of environmental factors in the adherence of an atypical enteropathogenic Escherichia coli strain to epithelial cells.

Authors:  Fabiano T Romão; Rodrigo T Hernandes; Denise Yamamoto; Lika Osugui; Ana Flavia Popi; Tânia A T Gomes
Journal:  BMC Microbiol       Date:  2014-12-20       Impact factor: 3.605

7.  Differential Regulation of the Surface-Exposed and Secreted SslE Lipoprotein in Extraintestinal Pathogenic Escherichia coli.

Authors:  Lendl Tan; Danilo G Moriel; Makrina Totsika; Scott A Beatson; Mark A Schembri
Journal:  PLoS One       Date:  2016-09-06       Impact factor: 3.240

Review 8.  Diarrheagenic Escherichia coli.

Authors:  Tânia A T Gomes; Waldir P Elias; Isabel C A Scaletsky; Beatriz E C Guth; Juliana F Rodrigues; Roxane M F Piazza; Luís C S Ferreira; Marina B Martinez
Journal:  Braz J Microbiol       Date:  2016-11-05       Impact factor: 2.476

9.  SslE elicits functional antibodies that impair in vitro mucinase activity and in vivo colonization by both intestinal and extraintestinal Escherichia coli strains.

Authors:  Barbara Nesta; Maria Valeri; Angela Spagnuolo; Roberto Rosini; Marirosa Mora; Paolo Donato; Christopher J Alteri; Mariangela Del Vecchio; Scilla Buccato; Alfredo Pezzicoli; Isabella Bertoldi; Lapo Buzzigoli; Giovanna Tuscano; Maria Falduto; Valentina Rippa; Yaqoub Ashhab; Giuliano Bensi; Maria Rita Fontana; Kate L Seib; Harry L T Mobley; Mariagrazia Pizza; Marco Soriani; Laura Serino
Journal:  PLoS Pathog       Date:  2014-05-08       Impact factor: 6.823

10.  Phenotypic and genotypic characteristics associated with biofilm formation in clinical isolates of atypical enteropathogenic Escherichia coli (aEPEC) strains.

Authors:  Heloisa H Nascimento; Lucas E P Silva; Renata T Souza; Neusa P Silva; Isabel C A Scaletsky
Journal:  BMC Microbiol       Date:  2014-07-10       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.